镰状细胞贫血患者的治疗依从性。 - Suppr

Suppr

超能文献

Treatment adherence in patients with sickle cell anemia.

作者信息

Drotar Dennis

出版信息

J Pediatr. 2010 Mar;156(3):350-1. doi: 10.1016/j.jpeds.2009.10.035. Epub 2010 Jan 8.

DOI:10.1016/j.jpeds.2009.10.035

PMID:20056235

Abstract

摘要

相似文献

Treatment adherence in patients with sickle cell anemia.

J Pediatr. 2010 Mar;156(3):350-1. doi: 10.1016/j.jpeds.2009.10.035. Epub 2010 Jan 8.

Sickle cell patients find a brand New World.

N J Med. 1999 Aug;96(8):23-5.

Hydroxyurea therapy: improving the lives of patients with sickle cell disease.

Pediatr Nurs. 2006 Nov-Dec;32(6):541-3.

Hydroxyurea and new agents for the treatment of sickle cell disease.

Clin Adv Hematol Oncol. 2004 Nov;2(11):713-5.

Hydroxyurea for the treatment of sickle cell anemia.

N Engl J Med. 2008 Mar 27;358(13):1362-9. doi: 10.1056/NEJMct0708272.

Hydroxyurea for sickle cell anemia.

N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9. doi: 10.1056/NEJMc080902.

Hydroxyurea in very young children with sickle cell anemia is not a cure-all.

J Pediatr. 2001 Dec;139(6):763-4. doi: 10.1067/mpd.2001.120093.

Hydroxyurea for sickle cell anemia.

N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9.

Hydroxyurea for children with sickle cell disease: are we starting too late?

Pediatr Blood Cancer. 2011 Jan;56(1):3-4. doi: 10.1002/pbc.22858.

Hydroxyurea for children with sickle cell disease.

Pediatr Clin North Am. 2008 Apr;55(2):483-501, x. doi: 10.1016/j.pcl.2008.02.003.

引用本文的文献

Caregiver and provider perspectives on developmental services for children with sickle cell disease: a mixed methods analysis.

Front Pediatr. 2025 Mar 21;13:1530457. doi: 10.3389/fped.2025.1530457. eCollection 2025.

Development and Validation of the Patient/Caregiver Reported Hydroxyurea Evaluation of Adherence for Life (HEAL) Scale.

Patient Prefer Adherence. 2022 Dec 10;16:3229-3239. doi: 10.2147/PPA.S387227. eCollection 2022.

Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease.

Pediatr Blood Cancer. 2019 Jul;66(7):e27740. doi: 10.1002/pbc.27740. Epub 2019 Apr 2.

Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10-18 years through community health workers: The HABIT study.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26689. Epub 2017 Jun 23.

Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.

Contemp Clin Trials. 2016 Jul;49:134-42. doi: 10.1016/j.cct.2016.06.004. Epub 2016 Jun 17.

Medication adherence among pediatric patients with sickle cell disease: a systematic review.

Pediatrics. 2014 Dec;134(6):1175-83. doi: 10.1542/peds.2014-0177. Epub 2014 Nov 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验